Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.10.2 extracted from

  • Bain, J.; McLauchlan, H.; Elliott, M.; Cohen, P.
    The specificities of protein kinase inhibitors: an update (2003), Biochem. J., 371, 199-204.
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
alsterpaullone at 0.01 mM: 66% inhibition of CHK, 81% inhibition of LCK, and 10% inhibition of CSK Homo sapiens
indirubin-3'-monoxime at 0.01 mM: 62% inhibition of CHK, 89% inhibition of LCK, but no inhibition of CSK Homo sapiens
kenpaullone at 0.01 mM: 35% inhibition of CHK, 85% inhibition of LCK, and 14% inhibition of CSK Homo sapiens
additional information no or poor inhibition of CHK1, LCK, and CSK by roscovitine Homo sapiens
purvalanol at 0.01 mM: 22% inhibition of CHK, 80% inhibition of LCK and CSK Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Synonyms

Synonyms Comment Organism
Chk1
-
Homo sapiens
Csk
-
Homo sapiens
Lck
-
Homo sapiens

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
21
-
assay at room temperature Homo sapiens

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
7.5
-
assay at Homo sapiens

Cofactor

Cofactor Comment Organism Structure
ATP
-
Homo sapiens